ROK
50
6
MTCH
53
-2
SWN
42
-4
LEG
17
-5
HBI
45
-7
BWA
40
-4
HCP
72
-2
MMC
53
-5
IFF
56
-6
AIZ
57
-7
APA
21
-3
APD
37
-3
AMGN
52
-5
NWL
19
-9
CMCSA
50
-2
AIG
51
-3
FTI
84
2
ORLY
58
-3
HAS
42
-6
NWS
86
3
ROK
50
6
MTCH
53
-2
SWN
42
-4
LEG
17
-5
HBI
45
-7
BWA
40
-4
HCP
72
-2
MMC
53
-5
IFF
56
-6
AIZ
57
-7
APA
21
-3
APD
37
-3
AMGN
52
-5
NWL
19
-9
CMCSA
50
-2
AIG
51
-3
FTI
84
2
ORLY
58
-3
HAS
42
-6
NWS
86
3
Financhill
Back

ProShares UltraShort Energy Vs. Keros Therapeutics Industry Stock Comparison

Sell
38

DUG
ProShares UltraShort Energy

Last Price:
9.65
Seasonality Move:
-0.37%
Sell
25

KROS
Keros Therapeutics

Last Price:
45.47
Seasonality Move:
4.22%
Sell
38
ProShares UltraShort Energy (DUG) is a Sell

Is ProShares UltraShort Energy a Buy, Sell or Hold?

  • The current ProShares UltraShort Energy [DUG] share price is $9.66. The Score for DUG is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • DUG is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Keros Therapeutics (KROS) is a Sell

Is Keros Therapeutics a Buy, Sell or Hold?

  • The current Keros Therapeutics [KROS] share price is $45.65. The Score for KROS is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DUG Stock Price Chart

What is ProShares UltraShort Energy's stock price today?

  • The ProShares UltraShort Energy share price today is $9.66
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DUG is experiencing selling pressure, which indicates risk of future bearish movement.

KROS Stock Price Chart

What is Keros Therapeutics's stock price today?

  • The Keros Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight selling pressure.

DUG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.12 Buy
Relative Strength Index (14 RSI): 44.34 Sell
Chaikin Money Flow: -72847 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.61 - 10.33) Sell
Bollinger Bands (100): (9 - 10.9) Sell

KROS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.91 Sell
Relative Strength Index (14 RSI): 36.74 Sell
Chaikin Money Flow: -120480 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.18 - 50.06) Sell
Bollinger Bands (100): (50.42 - 64.92) Sell

DUG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.22 Sell
20-day SMA: 10.07 Sell
50-day SMA: 9.58 Buy
200-day SMA: 10.68 Sell
8-day EMA: 10.04 Sell
20-day EMA: 10 Sell
50-day EMA: 9.83 Sell
200-day EMA: 10.8 Sell

KROS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 46.5 Sell
20-day SMA: 47.57 Sell
50-day SMA: 52.43 Sell
200-day SMA: 46.94 Sell
8-day EMA: 46.46 Sell
20-day EMA: 48 Sell
50-day EMA: 51.59 Sell
200-day EMA: 50.14 Sell

ProShares UltraShort Energy Earnings Growth & DUG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Keros Therapeutics Earnings Growth & KROS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.

ProShares UltraShort Energy Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Keros Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):